Umetrics announces TCGIvega as partner to provide a complete multivariate solution for Pharmaceutical Process Analytical Technology (PAT)
Kinnelon, New Jersey, January 28, 2005

Umetrics AB and TCGIvega are pleased to announce a partnership to provide integrated solutions for PAT in the pharmaceutical industry. The alliance enhances Umetrics' leading competence and software suites in multivariate/chemometrics analysis by adding TCGIvega's strong skills in data architecture design and integration. The objective of this partnership is to address the need for seamless data connectivity in the PAT domain. Currently, many pharmaceutical and biotech companies have separate data architecture systems such as MES (Manufacturing Execution System), LIMS (Lab Information Management System), and SCADA (Supervisory Control and Dada Acquisition) systems. It is increasingly difficult to connect these systems for the purpose of data analysis and process monitoring.

As outlined by the FDA, one objective of PAT is the multivariate analysis of realtime production data - whether in development and scale up, or in final production. This requires combining the information in all of these data systems. The strength of TCGIvega is extensive experience with integration of data systems in the life sciences industries. This partnership now extends the integration to include Umetrics' real-time and off-line multivariate software. Data will flow seamlessly from source to analysis and visualization. Umetrics' senior consultants will manage these projects and remove the stress from the pharmaceutical production facilities.

The solution ("Umetrics' PAT Suite") will be available to both production (primary and secondary manufacturing) as well as R&D environments where pharmaceutical and chemical development use multiple data sources.

"This partnership is a key step forward for Umetrics and our PAT products offering." says Umetrics' CEO Lars Osterberg. "Given the ability to harness all data sources simultaneously, in a robust and validated environment, our PAT solutions will perform process monitoring of all parts, from raw materials and API synthesis, to final product quality control. This is a unique offering in the industry."

TCGIvega CEO Giri Devanur adds, "Our strength in the enterprise integration space, and our long history in lifesciences nicely dovetails with Umetrics' unique PAT offerings, making for a true end-to-end solution." "It completes the missing lync that has been befuddling PAT practitioners", alluding to the DataLync realtime database connectivity product that TCGIvega is developing in collaboration with Umetrics and a major pharmaceutical company.

With over 17 years of experience of providing multivariate data analysis software to the pharmaceutical industry, Umetrics' products are uniquely suited for the PAT initiative. These products include SIMCA-Batch On-Line and SIMCA-P+.

About TCGIvega
TCGIvega is a leading global provider of IT-centric business solutions to Global 2000 companies across multiple verticals such as Finance, Pharmaceuticals, Energy, Manufacturing, Technology and Public Services, empowering clients to increase their business performance while reducing their cost structure. Over the past 10 years, TCGIvega's clients have realized significant business value by successfully leveraging upon TCGIvega's solution offerings. TCGIvega belongs to The Chatterjee Group (TCG), a private U.S. investment and money management firm with over $1.5 billion in strategic investments.

About Umetrics
Umetrics AB is a privately held company with its headquarters in Umea, Sweden. Since 1987, Umetrics' mission has been to ensure that clients add value to their businesses through the use of advanced data analysis and experimental design software and services. Umetrics is the worldwide recognized leader in the area of multivariate data analysis for industrial processes and applications.